Epiminder Ltd (EPI) - Total Liabilities
Based on the latest financial reports, Epiminder Ltd (EPI) has total liabilities worth AU$4.08 Million AUD (≈ $2.89 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Epiminder Ltd cash flow conversion to assess how effectively this company generates cash.
Epiminder Ltd - Total Liabilities Trend (2023–2025)
This chart illustrates how Epiminder Ltd's total liabilities have evolved over time, based on quarterly financial data. See EPI net assets for net asset value and shareholders' equity analysis.
Epiminder Ltd Competitors by Total Liabilities
The table below lists competitors of Epiminder Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bisichi Mining PLC
LSE:BISI
|
UK | GBX22.12 Million |
|
Trakm8 Holdings PLC
LSE:TRAK
|
UK | GBX16.34 Million |
|
Empire Metals Limited
LSE:GEO
|
UK | GBX834.10K |
|
MyHealthChecked Plc
LSE:MHC
|
UK | GBX2.78 Million |
|
VOLTAGE METALS CORP.
F:8L10
|
Germany | €1.63 Million |
|
Dekeloil Public Ltd
LSE:DKL
|
UK | GBX35.57 Million |
|
Kasikornbank Public Company Limited
F:TFBF
|
Germany | €3.88 Trillion |
Liability Composition Analysis (2023–2025)
This chart breaks down Epiminder Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Epiminder Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 23.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Epiminder Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Epiminder Ltd (2023–2025)
The table below shows the annual total liabilities of Epiminder Ltd from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$23.32 Million ≈ $16.50 Million |
-44.45% |
| 2024-06-30 | AU$41.99 Million ≈ $29.71 Million |
+19.32% |
| 2023-06-30 | AU$35.19 Million ≈ $24.90 Million |
-- |
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more